Tag: Multiple Sclerosis
Neuromodulation Methods Show Comparable Outcomes for Neurogenic Bladder in Women With MS
No significant difference seen in urodynamic testing results between TPTNS and rTMS groups
AAN: Tolebrutinib Slows Disability in Nonrelapsing Secondary Progressive MS
Tolebrutinib treatment associated with 31 percent risk reduction in six-month confirmed disability progression versus placebo
Higher Fish Intake Linked to Reduced Risk for MS Disability Worsening
More pronounced protective effects seen in patients who maintained consistent fish consumption during follow-up
Early Childhood Sun Exposure Linked to Lower Risk for Pediatric MS Relapse
Greater time spent in sun during second trimester of pregnancy also linked to reduced risk for relapse in offspring with MS
Multiple Sclerosis May Worsen With Menopause Transition
Findings show accumulation of neuronal injury and functional decline
Incidence, Prevalence of Peripartum Mental Illness Increased for Mothers With MS
Mothers with MS have higher incidence of any mental illness and of all mental illnesses except suicide
Adverse Outcomes Seen With MS Disease-Modifying Drugs in Pregnancy
Significant reductions seen in birth weight with exposure to certain DMTs, and increase seen in rate of small for gestational age
Children Have Various Symptoms Within Five Years Before MS Diagnosis
Nine ICD-10 codes were seen more often in children with multiple sclerosis versus controls without MS
COVID-19 Infection Not Linked to Changes in MS Symptom Severity
Immediate effect of COVID-19 infection on the SymptoMScreen total score was minimal
Certain Risk Factors for MS Linked to Pediatric Brain Volume
MS-polygenic risk score and household parental smoking negatively linked to total brain volume, thalamic volume
